INS and obesity disorder: Obesity is associated with substantial metabolic and endocrine abnormalities, including changes in sex hormone metabolism, insulin and insulin-like growth factor signaling, as well as adipokines or inflammatory pathways (Calle & Kaaks, 2004; Renehan, Zwahlen & Egger, 2015).